Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme

Showing 626 to 650 of 2013

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Empagliflozin for treating chronic heart failure with reduced ejection fractionTA773
Lenalidomide for relapsed or refractory mantle cell lymphoma (terminated appraisal)TA774
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA776
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA777
Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitisHTG617
Prontosan for treating acute and chronic woundsHTG616
3C Patch for treating diabetic foot ulcersHTG615
Mental wellbeing at workNG212
Intramedullary distraction for lower limb lengtheningHTG613
Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomachHTG612
Endoscopic balloon dilation for subglottic or tracheal stenosisHTG614
PredictSURE IBD and IBDX to guide treatment of Crohn's diseaseHTG610
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodulesHTG611
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapiesTA772
Odevixibat for treating progressive familial intrahepatic cholestasisHST17
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancerTA770
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)TA771
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableTA763
Fremanezumab for preventing migraineTA764
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA765
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanomaTA766
Ponesimod for treating relapsing–remitting multiple sclerosisTA767
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDsTA768
Palforzia for treating peanut allergy in children and young peopleTA769
Stereotactic radiosurgery for trigeminal neuralgiaHTG608

Results per page

  1. 10
  2. 25
  3. 50
  4. All